Intranasal Administration of DrugsSCHEIBE, Mandy; BETHGE, Christopher; WITT, Martin et al.Archives of otolaryngology, head & neck surgery. 2008, Vol 134, Num 6, pp 643-646, issn 0886-4470, 4 p.Article

Protollin: a novel adjuvant for intranasal vaccinesJONES, Taff; CYR, Sonya; ALLARD, Francine et al.Vaccine. 2004, Vol 22, Num 27-28, pp 3691-3697, issn 0264-410X, 7 p.Article

Intranasal cocaine functions as reinforcer on a progressive ratio schedule in humansSTOOPS, William W; LILE, Joshua A; GLASER, Paul E. A et al.European journal of pharmacology. 2010, Vol 644, Num 1-3, pp 101-105, issn 0014-2999, 5 p.Article

The Influence of Spray Properties on Intranasal DepositionMOW YEE FOO; CHENG, Yung-Sung; SU, Wei-Chung et al.Journal of aerosol medicine. 2007, Vol 20, Num 4, pp 495-508, issn 0894-2684, 14 p.Article

Intranasal Delivery of a Peptide with Antidepressant-Like EffectBROWN, Virginia; FANG LIU.Neuropsychopharmacology (New York, NY). 2014, Vol 39, Num 9, pp 2131-2141, issn 0893-133X, 11 p.Article

An effective regimen of intranasal salmon calcitonin in early postmenopausal bone lossGENNARI, C; AGNUSDEI, D; MONTAGNANI, M et al.Calcified tissue international. 1992, Vol 50, Num 4, pp 381-383, issn 0171-967XConference Paper

Small bowel enteroscopy in 1988: pros and consLEWIS, B. S; WAYE, J. D.The American journal of gastroenterology. 1988, Vol 83, Num 8, pp 799-802, issn 0002-9270Article

Nasal delivery of polypeptides. I: Nasal absorption of enkephalins in ratsSU, K. S. E; CAMPANALE, K. M; MENDELSOHN, L. G et al.Journal of pharmaceutical sciences. 1985, Vol 74, Num 4, pp 394-398, issn 0022-3549Article

Induction of serum and mucosal FIV-specific immune responses by intranasal immunization with p24GagLEAVELL, Sarah; WRIGHT, Brittany; SCAPPINO, Lori et al.Vaccine. 2005, Vol 23, Num 12, pp 1471-1478, issn 0264-410X, 8 p.Article

Relationship between systemic corticosteroid exposure and Growth velocity: Development and validation of a pharmacokinetic/pharmacodynamic modelDALEY-YATES, Peter T; RICHARDS, David H.Clinical therapeutics. 2004, Vol 26, Num 11, pp 1905-1919, issn 0149-2918, 15 p.Article

Effective intranasal therapeutics and prophylactics with monoclonal antibody against lethal infection of H7N7 influenza virusFANG HE; RAJESH KUMAR, Subaschandrabose; SYED MUSTHAQ SYED KHADER et al.Antiviral research. 2013, Vol 100, Num 1, pp 207-214, issn 0166-3542, 8 p.Article

Studies on the usefulness of intranasal inactivated influenza vaccines : Japanese Society of VaccinologyTAMURA, Shin-Ichi.Vaccine. 2010, Vol 28, Num 38, pp 6393-6397, issn 0264-410X, 5 p.Article

Enhanced nasal absorption of hydrophilic markers after dosing with AT 1002, a tight junction modulatorSONG, Keon-Hyoung; FASANO, Alessio; EDDINGTON, Natalie D et al.European journal of pharmaceutics and biopharmaceutics. 2008, Vol 69, Num 1, pp 231-237, issn 0939-6411, 7 p.Article

Subjective effects of an initial dose of nicotine nasal spray predict treatment outcomeKAUFMANN, Vyga; JEPSON, Christopher; RUKSTALIS, Margaret et al.Psychopharmacologia. 2004, Vol 172, Num 3, pp 271-276, issn 0033-3158, 6 p.Article

A triple gene mutant of BoHV-1 administered intranasally is significantly more efficacious than a BoHV-1 glycoprotein E-deleted virus against a virulent BoHV-1 challengeCHOWDHURY, Shafiqul I; HUIYONG WEI; WEISS, Marcello et al.Vaccine. 2014, Vol 32, Num 39, pp 4909-4915, issn 0264-410X, 7 p.Article

Rotavirus enterotoxin NSP4 has mucosal adjuvant propertiesKAVANAGH, Owen V; AJAMI, Nadim J; CHENG, Elly et al.Vaccine. 2010, Vol 28, Num 18, pp 3106-3111, issn 0264-410X, 6 p.Article

Comparison of the pulmonary response against lethal and non-lethal intranasal challenges with two different pneumococcal strainsFERREIRA, Daniela M; MORENO, Adriana T; CIANCIARULLO, Aurora M et al.Microbial pathogenesis. 2009, Vol 47, Num 3, pp 157-163, issn 0882-4010, 7 p.Article

Pharmaceutical Aspects of Intranasal Delivery of Vaccines Using Particulate SystemsSHARMA, Sameer; MUKKUR, T. K. S; BENSON, Heather A. E et al.Journal of pharmaceutical sciences. 2009, Vol 98, Num 3, pp 812-843, issn 0022-3549, 32 p.Article

Local immune responses following nasal delivery of an adjuvanted influenza vaccineSCHEERLINCK, Jean-Pierre Y; GEKAS, Susie; YEN, Hung-Hsun et al.Vaccine. 2006, Vol 24, Num 18, pp 3929-3936, issn 0264-410X, 8 p.Article

Strong local and systemic protective immunity induced in the ferret model by an intranasal virosome-formulated influenza subunit vaccineLAMBKIN, Rob; OXFORD, John S; BOSSUYT, Seb et al.Vaccine. 2004, Vol 22, Num 31-32, pp 4390-4396, issn 0264-410X, 7 p.Article

IFN-γ, but not IL-17A, is required for survival during secondary pulmonary Francisella tularensis Live Vaccine Stain infectionROBERTS, Lydia M; DAVIES, John S; SEMPOWSKI, Gregory D et al.Vaccine. 2014, Vol 32, Num 29, pp 3595-3603, issn 0264-410X, 9 p.Article

Different profile and distribution of antigen specific T cells induced by intranasal and intrarectal immunization with rotavirus 2/6-VLP with and without LT-R192GALKADAH, Abdelkarim; THIAM, Fatou; MOUNIER, Morgane et al.Vaccine. 2013, Vol 31, Num 15, pp 1924-1930, issn 0264-410X, 7 p.Article

Intranasal insulin improves memory in humans : Superiority of insulin aspartBENEDICT, Christian; HALLSCHMID, Manfred; SCHMITZ, Katrin et al.Neuropsychopharmacology (New York, NY). 2007, Vol 32, Num 1, pp 239-243, issn 0893-133X, 5 p.Article

Enhancement of intranasal vaccination in mice with deglycosylated chain A ricin by LTR72, a novel mucosal adjuvantKENDE, Meir; DEL GIUDICE, Giuseppe; RIVERA, Noelia et al.Vaccine. 2006, Vol 24, Num 12, pp 2213-2221, issn 0264-410X, 9 p.Article

A personnel time-motion study of intranasal influenza vaccination in healthy childrenWASHINGTON, Michael L; HUMISTON, Sharon G; FAUERBACH, Peter B et al.Vaccine. 2005, Vol 23, Num 40, pp 4879-4885, issn 0264-410X, 7 p.Article